Genmab | GEN - Market Capitalization


Genmab reported DKK111.69B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
argenx SE USD 51.83B 7.52B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Demant DKK 46.01B 10.48B Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Fresenius Medical Care EUR 11.96B 1.14B Dec/2025
Galapagos EUR 1.85B 76.44M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
GN Store Nord DKK 16.11B 98.09M Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025